What is Filana Therapeutics, Inc.?
, a clinical stage biotechnology company, develops drugs for neurodegenerative diseases.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is in Phase 3 clinical trial to treat Alzheimer's disease; and investigational diagnostic product candidate is SavaDx, an early-stage program focused on detecting the presence of Alzheimer's disease from a small sample of blood. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 32.26M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.